Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 72.8;lymphoid tissue: 93.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 63.7;granulocytes: 201.3;Hofbauer cells: 85.0;Kupffer cells: 78.5;Macrophages: 86.5;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 13.9;Daudi: 40.9;HMC-1: 24.0;U-266/70: 30.8;U-698: 11.0"	"Region enriched"	"Detected in single"	4	"white matter: 2.9"	"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	16.8	8.4	1.4	8.4	1.1	31.1	12.7	2.8	2.9	6.1	1.0	11.0	3.0	6.9	0.3	10.7	11.1	3.4	6.7	1.2	1.8	8.3	5.5	72.8	6.7	4.1	2.5	2.6	23.2	0.9	3.2	3.6	2.7	11.8	2.3	0.1	14.1	1.5	2.1	5.6	35.8	4.9	2.5	93.9	9.3	2.1	2.2	2.6	4.7	3.7	8.9	40.0	7.9	4.2	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	7.4	40.9	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	8.6	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	2.7	0.0	5.2	0.7	0.0	0.0	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.2	0.0	0.0	30.8	2.8	11.0	0.0	0.1	0.0	462.5	225.6	317.6	0.3	198.4	0.6	133.9	5.3	1.7	119.7	98.5	0.7	0.5	457.8	0.2	210.5	2.4	1.2	136.1	1.4	1.1	2.8	2.9	1.2	1.8	4.1	2.5	2.7	2.5	2.2	4.2	0.7	16.0	38.4	1.3	63.7	1.1	7.3	0.2	1.2	1.3	7.3	4.3	2.2	12.8	9.5	9.2	2.1	0.7	1.7	1.7	0.0	20.9	0.5	0.7	0.5	3.0	7.1	1.7	2.8	21.6	2.0	1.7	13.7	4.4	201.3	2.2	3.6	1.1	85.0	0.0	1.1	2.0	14.2	78.5	17.8	1.1	0.3	86.5	0.0	47.8	59.5	0.7	4.1	4.0	1.4	18.4	0.6	0.0	13.8	4.0	9.4	0.2	2.6	0.3	13.1	0.3	1.1	0.3	1.1	9.2	1.4	4.1	5.9	0.7	3.2	45.3
CDKN2D	"INK4D, p19"	ENSG00000129355	"Cyclin dependent kinase inhibitor 2D"	P55273	19	10566460-10569059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 283.7"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 146.8;Erythroid cells: 116.6;Macrophages: 105.4;NK-cells: 155.5;Spermatocytes: 126.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 90.6;MOLT-4: 113.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011201, HPA043546"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"CAB011201: AB_261049, HPA043546: AB_2678545"	"unprognostic (3.08e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.55e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.90e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	13.7	9.8	61.0	13.3	64.9	283.7	9.5	43.9	86.9	9.4	37.3	14.2	6.3	7.0	3.1	14.3	11.0	6.4	18.8	64.8	59.7	11.3	7.1	30.8	23.9	53.8	51.5	7.1	5.8	3.3	15.7	8.2	59.9	8.0	5.6	16.3	7.3	4.1	19.7	18.1	14.5	7.8	46.1	42.4	9.4	38.6	57.6	78.0	6.2	15.9	16.1	11.2	12.9	57.4	30.8	4.8	15.1	10.0	8.0	12.2	3.8	19.8	23.2	21.4	18.8	6.1	7.3	8.5	6.4	21.1	21.6	6.4	5.2	5.1	7.7	34.3	12.6	90.6	5.8	10.2	9.2	9.2	70.2	5.1	16.2	11.0	8.2	17.7	6.1	52.6	3.8	72.3	21.5	4.3	113.9	48.3	3.0	23.4	22.7	18.4	14.7	5.1	9.7	2.6	21.3	11.2	14.0	10.4	15.2	2.8	9.4	24.0	4.7	25.2	12.9	42.1	30.1	44.9	16.5	15.8	26.7	15.5	18.4	143.5	17.7	79.7	30.2	23.2	24.2	56.7	24.9	34.1	17.4	50.0	23.3	27.4	139.9	41.1	35.6	51.0	22.5	31.8	61.0	64.9	43.9	86.9	64.8	59.7	53.8	51.5	59.9	46.1	57.6	57.4	35.2	6.4	7.0	4.6	65.2	23.2	13.7	17.1	38.7	32.4	11.1	15.2	9.2	5.7	8.2	5.5	12.5	4.8	146.8	11.8	9.8	7.7	21.2	26.9	10.2	29.3	7.2	116.6	18.5	4.9	8.4	11.0	3.6	16.7	21.0	4.8	26.7	3.8	10.4	47.1	14.8	6.4	36.7	42.2	47.7	13.7	7.2	105.4	30.2	1.9	46.4	22.2	155.5	1.0	8.2	14.2	9.4	6.0	9.2	11.4	5.0	5.1	10.9	37.1	19.7	8.3	25.8	126.0	83.7	38.6	33.1	4.9	63.4	4.5	6.9	23.8
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cell line enhanced"	"Detected in some"		"HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	68.0	24.8	7.3	101.7	6.6	48.6	13.3	8.0	12.1	18.1	13.9	16.0	8.1	7.3	4.3	11.7	14.6	36.8	11.5	6.5	11.5	12.7	12.3	77.5	16.1	15.1	11.4	7.2	12.7	8.5	7.6	107.3	13.3	6.1	21.0	2.3	9.9	9.6	2.6	3.5	10.8	40.9	11.9	61.8	10.1	4.4	13.8	9.8	6.4	10.2	7.7	68.3	5.2	21.8	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	29.4	0.3	0.0	0.7	8.6	56.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	17.9	0.5	0.0	0.0	0.4	15.8	0.0	0.0	1.1	0.2	1.2	8.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	61.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.4	26.7	6.6	2.4	358.3	421.8	0.7	268.4	1.0	3.2	0.5	0.4	89.9	1.7	0.4	0.7	2322.4	0.4	232.7	3.8	0.9	170.3	7.3	6.6	8.0	12.1	6.5	11.5	15.1	11.4	13.3	11.9	13.8	21.8	2.3	22.4	49.1	0.0	8.6	8.7	0.9	0.3	1.2	0.4	1.1	3.8	1.8	2.8	12.1	0.0	0.0	1.0	3.4	0.1	9.8	0.2	38.2	0.1	0.8	15.6	0.0	3.0	0.1	0.6	1.6	8.9	1.1	0.1	30.4	0.1	3.9	2.1	178.2	0.0	0.1	0.0	0.0	159.1	336.6	66.5	1.5	305.0	17.8	12.2	97.3	0.5	7.2	1.0	0.6	0.5	0.0	0.0	4.6	0.3	0.0	9.6	3.7	0.2	6.6	1.5	6.0	0.4	0.6	0.8	7.7	1.6	4.8	0.2	0.1	0.4
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 207.8;lung: 86.5;lymphoid tissue: 141.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 182.2;Langerhans cells: 63.8;Macrophages: 155.9;monocytes: 159.7;NK-cells: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 86.0;U-266/70: 153.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	25.0	6.8	12.8	62.2	11.9	207.8	16.0	11.9	19.1	7.6	11.5	6.0	3.9	8.1	1.7	5.2	15.6	12.7	8.7	11.4	12.3	7.5	10.8	86.5	27.5	13.6	12.7	2.9	5.8	1.6	2.7	7.9	14.5	7.2	4.0	0.7	6.6	2.4	3.2	4.5	10.1	16.3	12.5	141.1	5.9	2.5	17.2	8.4	7.4	6.5	20.0	17.8	7.3	12.6	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.7	29.3	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	3.8	5.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	153.1	2.1	6.5	0.0	19.5	0.0	30.8	381.4	229.4	189.5	469.1	11.3	54.0	15.8	89.1	196.1	84.0	8.0	78.4	272.9	264.5	405.2	9.0	1.2	494.1	12.8	11.9	11.9	19.1	11.4	12.3	13.6	12.7	14.5	12.5	17.2	12.6	8.6	6.4	20.0	0.0	24.9	2.8	0.6	0.2	0.0	0.0	0.4	0.6	1.6	1.5	5.7	1.8	0.0	0.5	55.2	0.0	0.0	0.0	0.3	0.1	0.2	14.9	0.0	7.4	0.2	0.2	0.7	2.7	1.5	0.1	13.3	0.1	6.8	1.9	56.8	0.0	0.1	0.0	0.0	182.2	63.8	0.7	0.3	155.9	1.8	6.5	159.7	0.1	259.5	1.0	0.4	0.0	1.2	0.0	4.2	0.4	0.0	0.7	1.5	0.0	0.0	0.7	0.6	0.2	0.5	0.5	1.1	1.0	28.0	0.0	0.0	2.5
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.0;Hofbauer cells: 12.7;Kupffer cells: 18.8;Late spermatids: 26.8;Macrophages: 61.3;monocytes: 23.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1187.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1187.9"	"Cell line enriched"	"Detected in some"	20	"U-937: 32.7"	"Not detected"	"Not detected"							HPA029154	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	13.6	1.2	0.3	56.1	0.6	16.6	0.6	0.3	2.6	0.5	0.9	0.8	1.0	0.5	0.1	1.8	1.8	5.9	0.9	0.3	0.3	0.4	4.9	9.4	1.9	0.6	0.5	1.5	2.3	0.3	0.2	7.6	0.9	0.4	0.5	0.1	0.5	0.3	0.3	0.4	1.3	6.7	0.3	17.2	0.7	2.4	1.2	1.6	0.7	4.2	0.8	15.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.9	32.7	0.0	3.6	122.0	5.8	0.2	122.7	0.7	0.1	0.2	0.2	16.6	0.2	0.1	0.2	1187.9	0.2	85.0	3.3	0.1	46.0	0.3	0.6	0.3	2.6	0.3	0.3	0.6	0.5	0.9	0.3	1.2	0.5	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	9.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	5.1	0.0	0.4	0.4	12.7	0.0	0.0	0.0	0.0	18.8	0.8	26.8	0.0	61.3	0.0	0.0	23.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 325.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 185.0;Kupffer cells: 183.3;Macrophages: 153.5;monocytes: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 327.4;neutrophil: 864.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 864.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	30.5	13.5	16.4	62.6	23.0	325.7	17.6	20.2	28.8	12.2	11.4	18.0	19.3	9.8	24.6	10.9	16.2	23.0	9.7	15.9	17.7	18.3	15.0	26.5	33.0	25.5	20.7	8.5	16.6	10.4	8.2	25.2	23.6	12.2	19.6	10.6	12.3	9.7	2.7	7.0	18.7	18.8	21.6	70.1	25.1	24.1	19.5	18.4	17.0	14.9	25.4	26.1	5.7	37.3	2.6	4.2	10.7	0.0	2.5	2.2	0.4	4.0	11.1	6.2	11.1	8.7	30.6	3.7	27.0	0.3	14.2	1.6	4.1	12.7	7.7	17.1	16.8	33.5	2.9	17.7	3.0	41.6	9.1	2.8	4.3	5.7	1.2	15.8	0.9	25.9	0.6	12.1	0.5	33.0	0.9	24.2	6.5	22.5	16.4	14.2	2.7	18.5	32.7	18.6	6.9	12.0	5.1	23.3	19.7	12.5	15.8	17.7	0.8	1.6	11.2	17.8	6.2	11.5	23.2	0.6	9.2	15.8	7.7	38.8	132.4	327.4	2.7	78.4	3.5	21.6	4.8	4.8	63.2	21.1	8.1	5.0	864.2	2.5	63.3	17.2	10.2	71.4	16.4	23.0	20.2	28.8	15.9	17.7	25.5	20.7	23.6	21.6	19.5	37.3	28.8	16.0	36.5	10.1	54.5	15.4	28.2	19.6	12.5	10.2	32.6	16.4	4.1	50.1	21.2	33.1	2.1	55.5	17.3	14.4	76.3	49.5	185.0	21.1	9.1	26.4	39.4	36.1	25.9	60.5	20.8	14.4	43.8	24.9	44.9	13.6	48.9	15.0	107.9	11.8	15.4	29.9	32.6	183.3	60.5	32.8	10.8	153.5	16.0	17.8	228.5	21.1	10.3	1.0	98.0	36.5	25.7	6.4	23.4	24.3	18.4	69.7	24.7	4.4	6.6	12.2	18.3	52.6	13.5	15.1	18.2	46.9	16.3	16.7	28.9	21.0
HRH2		ENSG00000113749	"Histamine receptor H2"	P25021	5	175658030-175710756	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.0;heart muscle: 26.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 26.2;Excitatory neurons: 62.2;Inhibitory neurons: 19.1;Kupffer cells: 29.4;Macrophages: 36.2;monocytes: 24.3;Smooth muscle cells: 33.6"	"Group enriched"	"Detected in many"	5	"melanoma: 2.9;renal cancer: 4.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 134.4;neutrophil: 161.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 161.7;monocytes: 51.6"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 65.6;SK-MEL-30: 19.2;THP-1: 18.0;U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013770	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA013770: AB_1851086"	"unprognostic (8.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.77e-2)"	7.6	1.5	4.5	12.0	14.4	37.0	3.0	1.1	9.6	5.1	0.5	1.4	6.2	2.2	0.9	1.4	2.9	2.5	26.3	5.3	1.4	2.3	1.0	7.2	3.8	1.2	1.6	1.1	1.5	1.3	0.8	10.2	1.1	4.7	1.1	0.3	1.4	4.6	0.8	2.2	6.4	3.6	1.7	18.0	19.5	0.5	3.9	8.5	1.5	1.5	3.1	4.1	2.0	5.1	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	5.0	2.9	0.0	0.0	7.1	0.0	65.6	0.0	0.3	0.5	0.0	0.0	0.0	19.2	1.7	0.1	18.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.6	4.3	134.4	45.8	52.8	0.2	44.9	0.3	0.0	3.8	1.0	23.5	0.1	7.9	4.8	161.7	2.1	51.6	18.3	3.3	15.3	4.5	14.4	1.1	9.6	5.3	1.4	1.2	1.6	1.1	1.7	3.9	5.1	1.1	0.0	2.5	1.0	1.0	0.8	0.1	0.0	0.6	9.3	3.7	0.9	26.2	0.0	2.5	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.6	0.1	0.8	1.9	0.0	3.0	62.2	2.4	0.2	3.3	7.1	0.1	2.5	3.0	0.0	0.2	11.8	1.7	19.1	0.6	0.0	29.4	8.5	1.0	0.0	36.2	0.0	10.3	24.3	0.1	0.0	1.5	1.7	0.3	0.0	0.4	0.3	0.2	0.6	0.3	0.7	0.2	0.0	0.1	33.6	0.2	0.9	0.1	0.3	0.0	4.7	0.1	0.5	0.0
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 24.2;lymphoid tissue: 18.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.7;granulocytes: 111.2;Langerhans cells: 25.4;NK-cells: 42.2;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HHSteC: 35.4;U-937: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007615	Approved		Approved	Mitochondria		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	8.2	2.3	1.3	5.6	1.4	2.4	5.4	1.2	1.9	4.5	1.6	4.0	4.1	3.1	1.6	2.2	3.7	2.9	4.5	1.0	2.4	4.4	6.6	24.2	4.1	1.5	1.3	1.1	1.3	3.2	1.7	6.9	1.8	3.3	1.0	0.2	2.2	5.7	0.9	2.6	8.8	0.7	1.3	18.5	4.3	0.5	2.0	2.0	2.1	1.1	2.2	4.0	2.8	1.3	1.8	0.6	0.0	0.0	1.3	0.8	2.3	0.0	1.1	0.1	0.5	0.0	0.8	0.0	0.1	0.0	3.4	0.9	0.0	2.4	0.0	27.4	1.2	2.1	0.5	0.1	35.4	8.8	10.1	7.8	1.9	3.1	5.4	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.4	1.1	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.8	0.9	0.5	3.2	0.6	0.0	0.0	0.0	0.1	52.0	3.6	10.0	0.0	4.8	6.2	0.1	16.3	0.1	3.6	4.7	3.6	0.2	0.6	1.4	6.7	45.6	0.0	10.4	4.1	1.9	1.3	1.4	1.2	1.9	1.0	2.4	1.5	1.3	1.8	1.3	2.0	1.3	10.2	0.0	8.5	0.3	2.7	0.8	1.1	1.1	0.6	0.0	0.3	0.3	3.9	0.0	2.3	1.8	0.0	0.0	44.7	0.3	1.9	0.9	0.1	1.0	4.1	7.4	0.0	3.6	0.2	0.6	1.0	3.1	5.1	1.1	111.2	0.0	10.0	7.6	0.1	0.0	1.0	0.1	0.0	2.4	25.4	0.1	0.3	16.5	3.6	12.2	1.0	0.2	42.2	1.5	0.0	1.1	0.4	0.0	10.3	1.0	0.1	0.9	3.8	0.2	6.6	0.9	1.4	0.4	1.3	0.3	1.0	0.0	25.4	0.1	0.4	0.9
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 48.1;brain: 33.7;lung: 58.1;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 51.1;granulocytes: 74.0;Hofbauer cells: 45.1;Kupffer cells: 51.5;Langerhans cells: 77.3;Macrophages: 141.7;Microglial cells: 56.2;NK-cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 87.5"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 106.1"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871"	Enhanced					NA	NA		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	12.9	2.3	6.0	42.7	8.1	48.1	4.3	8.8	33.7	2.2	8.4	2.9	2.3	2.8	0.8	2.0	5.9	10.8	3.5	6.2	9.3	2.9	6.3	58.1	23.2	14.6	11.8	1.0	2.9	1.4	2.9	4.6	14.3	3.2	4.3	0.6	4.5	1.5	1.3	2.1	5.5	4.7	13.0	67.5	4.8	0.6	18.4	4.0	2.8	3.2	12.3	9.2	2.1	24.8	0.1	0.6	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	9.0	0.0	0.3	0.1	0.0	0.3	0.1	18.6	0.1	0.1	0.3	0.4	0.0	1.1	106.1	0.1	0.1	1.7	0.2	0.7	1.0	0.0	0.1	0.4	0.0	0.0	0.1	8.8	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.1	0.0	3.3	0.8	0.0	1.6	0.0	0.1	0.1	0.0	0.2	4.9	1.8	0.3	12.8	29.1	27.1	4.8	50.3	0.4	2.1	0.1	0.7	34.7	1.0	0.1	0.7	87.5	41.4	61.0	0.6	0.1	11.5	6.0	8.1	8.8	33.7	6.2	9.3	14.6	11.8	14.3	13.0	18.4	24.8	0.8	12.8	51.1	0.0	9.8	2.8	0.3	0.0	0.0	0.1	0.6	1.3	1.5	0.0	10.5	0.0	0.0	0.4	33.6	0.0	0.0	0.3	0.0	0.4	0.5	4.8	0.0	3.4	0.2	0.0	0.6	4.4	0.0	0.5	74.0	0.0	1.1	0.1	45.1	0.0	0.3	0.0	0.0	51.5	77.3	0.0	0.0	141.7	1.8	56.2	35.3	0.1	68.0	0.5	0.3	0.2	0.0	0.0	5.5	0.2	0.0	0.3	1.5	0.1	0.0	0.6	1.0	0.0	0.2	0.0	1.1	0.4	16.5	0.1	0.0	0.1
LILRB3	"CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB"	ENSG00000204577	"Leukocyte immunoglobulin like receptor B3"	O75022	19	54216278-54223506	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.0;lymphoid tissue: 49.9"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 63.4;Kupffer cells: 88.6;Macrophages: 88.8;monocytes: 71.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 44.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 44.8;monocytes: 15.4"	"Not detected"	"Not detected"											HPA026985			Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"HPA026985: "	"unprognostic (7.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.83e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.92e-8)"	"unprognostic (2.18e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-1)"	9.9	3.4	0.4	8.3	0.4	14.6	2.9	0.4	2.1	1.2	0.9	2.7	0.3	1.2	0.3	1.3	5.4	0.1	3.4	0.4	0.4	2.3	4.1	27.0	0.3	1.2	0.8	1.0	1.9	0.0	1.3	1.2	1.3	1.7	0.0	0.2	2.4	0.0	1.1	0.8	2.6	0.1	0.6	49.9	2.3	0.5	1.8	0.6	1.6	0.0	0.2	3.2	1.6	1.4	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	15.4	0.6	0.1	14.3	0.2	0.1	0.3	0.0	7.2	0.1	0.0	0.1	44.8	0.0	5.6	0.5	0.0	11.6	0.4	0.4	0.4	2.1	0.4	0.4	1.2	0.8	1.3	0.6	1.8	1.4	1.5	9.6	13.0	0.3	2.2	2.4	1.2	6.5	0.0	0.7	1.6	2.2	0.4	4.3	8.3	1.8	0.0	1.5	2.1	0.6	0.0	0.3	1.3	0.8	1.9	3.0	0.0	0.8	0.2	0.6	6.7	2.9	0.0	2.2	7.6	0.5	1.8	3.2	63.4	0.0	0.1	1.9	0.0	88.6	8.4	4.1	0.3	88.8	1.8	1.9	71.2	0.9	3.1	0.0	0.1	0.2	1.3	0.7	2.1	1.6	0.4	0.4	5.2	2.9	6.6	4.3	1.3	0.8	1.5	0.1	3.0	1.2	3.8	2.6	2.0	0.4
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30434021-30461833	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 332.1"	"Cell type enhanced"	"Detected in many"		"Macrophages: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	69.1	18.8	7.2	39.9	5.8	332.1	31.8	5.9	8.0	15.1	22.1	19.6	8.3	18.3	5.9	23.2	38.0	37.4	18.5	6.7	13.5	12.7	16.2	64.5	33.7	10.7	8.1	12.0	7.4	6.9	8.4	46.5	8.8	11.1	16.4	10.9	12.5	11.2	6.6	36.0	21.1	35.6	9.3	41.7	20.3	3.0	15.9	9.3	14.7	6.1	28.8	49.4	20.4	7.9	15.5	13.7	3.6	7.7	18.3	15.4	17.3	3.8	20.3	8.2	9.6	9.4	34.2	10.3	9.2	8.1	8.1	28.2	8.4	3.7	3.0	23.3	4.4	19.2	25.6	30.8	16.0	6.0	44.2	19.5	2.1	7.4	1.6	7.7	3.6	0.2	8.8	14.7	1.4	8.8	0.2	22.3	1.4	8.3	4.9	1.3	3.0	5.8	7.9	30.8	0.3	1.6	13.7	11.3	1.9	10.0	3.7	12.7	0.1	4.8	4.3	18.0	0.6	22.4	22.7	3.2	6.9	25.3	0.2	45.8	14.7	53.1	15.7	26.4	8.7	20.8	3.3	10.3	14.5	38.0	0.2	6.0	35.5	28.3	38.7	30.0	1.0	10.3	7.2	5.8	5.9	8.0	6.7	13.5	10.7	8.1	8.8	9.3	15.9	7.9	51.0	38.5	49.6	11.8	147.3	116.9	50.0	91.1	109.8	19.0	51.7	24.3	10.1	11.5	67.5	3.7	0.0	29.3	203.6	13.6	1.9	31.4	0.5	149.3	51.4	55.7	12.0	21.2	7.7	11.3	86.8	66.2	33.1	205.6	71.1	1.1	25.0	3.1	128.2	0.0	7.1	6.3	83.4	113.8	205.5	1.1	8.4	225.1	42.7	30.9	64.7	6.1	36.0	2.0	0.7	23.4	20.7	4.1	107.8	46.8	3.9	3.5	78.8	1.6	6.6	23.6	62.3	0.3	0.8	129.1	84.8	159.4	97.8	1.5	6.5	195.6
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555562-183590876	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 191.9;lung: 74.6;lymphoid tissue: 78.8"	"Group enriched"	"Detected in many"	5	"Ductal cells: 68.6;Hofbauer cells: 212.0;Kupffer cells: 137.9;Langerhans cells: 129.5;Macrophages: 194.4;monocytes: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1313.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 26.4;HMC-1: 21.4;hTERT-HME1: 51.6;RPMI-8226: 20.0;U-2 OS: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	29.9	5.8	2.7	76.9	3.0	191.9	7.0	3.2	14.6	9.5	4.5	10.4	8.5	4.1	1.6	7.6	8.0	23.8	5.6	2.3	3.9	3.7	12.7	74.6	17.3	6.2	4.2	2.1	4.6	2.8	2.7	39.7	6.8	2.9	12.5	0.8	6.6	3.5	3.7	15.9	12.4	20.4	4.5	78.8	5.8	2.1	12.0	11.3	3.0	11.5	16.9	24.2	5.9	7.8	26.4	0.8	0.0	0.0	0.0	0.0	0.3	1.9	2.4	3.4	1.6	0.2	0.8	3.2	4.3	0.8	0.6	14.3	0.1	19.0	3.1	16.2	0.0	0.0	7.3	6.0	0.0	2.0	21.4	0.0	4.1	3.4	51.6	2.2	0.0	0.1	0.0	5.6	5.8	0.2	0.2	1.1	0.4	1.5	1.5	7.0	2.2	20.0	0.8	0.2	0.0	0.1	0.3	0.1	0.9	1.7	2.8	9.1	1.2	0.1	50.2	0.0	4.9	0.9	1.4	0.6	0.4	10.3	0.0	199.5	489.2	1313.6	1.0	348.8	1.6	14.1	4.0	1.6	246.0	10.8	2.2	1.3	799.7	2.1	326.1	13.5	11.1	298.9	2.7	3.0	3.2	14.6	2.3	3.9	6.2	4.2	6.8	4.5	12.0	7.8	0.7	9.6	15.7	0.0	8.4	5.5	0.2	13.7	1.8	0.3	0.1	0.3	1.3	7.2	17.3	0.0	0.0	1.0	9.6	0.1	3.9	68.6	1.1	1.9	0.5	3.5	0.0	1.7	0.3	3.9	1.1	2.0	0.5	1.3	7.6	0.0	3.3	1.0	212.0	0.0	0.3	0.2	26.4	137.9	129.5	2.9	0.6	194.4	7.2	3.7	223.6	0.0	6.2	0.0	0.2	27.3	2.6	0.0	3.2	0.6	0.0	0.3	32.0	0.7	13.1	0.7	6.8	0.1	0.6	0.6	4.3	1.9	3.7	0.2	0.0	1.2
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793741-53824394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 7.4;granulocytes: 7.6;Kupffer cells: 11.2;Macrophages: 7.8;monocytes: 20.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;classical monocyte: 18.1;eosinophil: 23.2;neutrophil: 29.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 56.9;monocytes: 18.1"	"Group enriched"	"Detected in some"	4	"HMC-1: 4.6;THP-1: 4.1;U-87 MG: 4.3;U-937: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042981	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	0.9	0.0	0.1	2.2	0.1	6.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.1	4.3	0.1	0.1	0.3	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	3.8	0.0	56.9	18.1	23.2	0.0	5.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	29.8	0.0	3.0	0.1	0.0	5.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.3	6.4	7.4	0.0	0.5	0.4	1.0	0.1	0.0	0.7	0.2	0.1	0.5	0.0	3.7	0.0	0.0	0.2	1.4	0.2	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.7	0.0	0.2	1.5	0.0	0.3	7.6	0.2	0.7	0.0	2.4	0.0	0.8	0.0	0.0	11.2	1.6	0.2	0.3	7.8	1.8	0.0	20.5	0.2	2.1	0.0	0.5	0.1	0.0	0.0	0.3	0.8	0.0	0.1	2.2	0.7	0.0	0.7	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.7
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669049-7670455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 247.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 118.2;Kupffer cells: 47.0;Macrophages: 90.4;monocytes: 58.2"	"Group enriched"	"Detected in many"	4	"lung cancer: 2.6;pancreatic cancer: 4.8;thyroid cancer: 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"classical monocyte: 170.4;intermediate monocyte: 91.7;myeloid DC: 118.7;non-classical monocyte: 47.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 118.7;monocytes: 170.4"	"Group enriched"	"Detected in some"	11	"NB-4: 524.3;U-937: 243.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	5120000	1200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"	3.4	1.0	0.1	5.2	0.1	247.2	1.4	0.0	0.9	0.6	0.0	0.8	6.1	0.7	0.0	0.5	2.4	0.3	2.3	0.4	0.1	1.7	3.3	34.0	0.1	0.1	0.1	0.4	0.9	0.1	0.5	1.1	0.1	1.0	0.2	0.0	1.1	0.0	0.6	0.7	0.7	4.3	0.0	53.3	1.0	0.2	0.0	4.0	0.8	0.0	0.0	0.6	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.9	524.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	243.2	0.0	0.1	170.4	0.1	0.4	91.7	1.2	0.0	1.9	1.5	118.7	0.1	4.4	9.0	13.6	0.3	47.4	4.5	0.0	64.3	0.1	0.1	0.0	0.9	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	12.8	9.9	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.5	0.0	0.0	1.1	0.6	0.0	0.0	3.8	0.0	0.4	0.1	118.2	0.0	0.0	0.0	0.0	47.0	8.7	0.2	0.0	90.4	0.0	0.0	58.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.5	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.1	2.2	0.0	0.0	0.1
RNF175	FLJ34190	ENSG00000145428	"Ring finger protein 175"	Q8N4F7	4	153710160-153760024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;choroid plexus: 10.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 72.8;Excitatory neurons: 91.4;Inhibitory neurons: 95.7;Oligodendrocyte precursor cells: 38.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HSkMC: 5.8;REH: 6.7;SH-SY5Y: 7.6;THP-1: 17.5;U-87 MG: 4.5"									HPA035837	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035837: AB_10601609"	"unprognostic (3.23e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.63e-4)"	"unprognostic (7.25e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	1.5	2.5	18.8	2.9	19.2	6.1	0.8	15.0	27.6	3.0	10.8	0.6	0.1	0.2	0.9	0.6	0.5	1.0	4.0	18.3	21.8	0.2	0.4	1.4	1.2	17.7	15.3	0.1	0.3	0.0	4.0	0.1	17.6	2.4	0.1	3.5	1.4	3.4	0.1	0.7	0.5	0.1	14.1	2.5	0.3	1.6	18.0	0.1	0.2	0.5	0.6	0.5	1.5	17.5	0.2	0.0	8.8	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	6.7	0.0	0.3	0.0	0.1	0.0	7.6	0.0	0.0	0.2	0.1	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.0	2.4	0.0	2.1	0.0	0.6	0.6	18.8	19.2	15.0	27.6	18.3	21.8	17.7	15.3	17.6	14.1	18.0	17.5	0.1	0.0	0.5	6.8	0.0	0.4	0.1	0.6	0.6	0.7	0.1	0.6	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.8	0.0	0.1	0.2	0.0	0.4	91.4	0.0	0.0	2.9	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	95.7	0.0	0.0	5.9	2.9	14.6	0.0	1.5	1.8	2.8	0.7	0.8	0.0	38.7	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	1.6	0.0	0.0	0.3	1.5	1.3	0.0	0.3	0.0	0.6	0.0	0.0	0.2
SBNO2	"FLJ00173, KIAA0963, Sno, Stno"	ENSG00000064932	"Strawberry notch homolog 2"	Q9Y2G9	19	1107637-1174268	"Predicted intracellular proteins"	"Differentiation, Osteogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 45.3;HDLM-2: 65.2;U-266/70: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041867	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"			"HPA041867: AB_2677715"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (8.48e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (7.98e-8)"	"unprognostic (1.34e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.88e-1)"	61.3	42.8	2.8	8.5	2.9	11.4	40.2	1.8	5.0	35.7	4.6	31.8	1.9	28.0	0.2	51.8	33.8	3.0	27.1	0.9	3.2	57.8	41.5	68.4	2.7	12.0	5.4	30.9	21.4	0.2	37.8	2.4	5.4	42.7	0.3	0.1	42.9	0.7	38.6	43.0	30.8	2.1	3.5	60.0	30.0	19.3	8.6	1.5	34.2	0.5	2.5	32.1	35.7	5.5	45.3	5.7	0.8	0.5	0.1	2.8	16.1	13.0	1.4	2.9	1.6	0.3	7.3	9.0	18.2	2.2	2.3	14.6	0.0	2.0	1.0	65.2	9.8	9.9	18.3	0.1	2.4	5.8	28.7	6.8	1.8	4.3	1.7	2.2	2.8	3.9	15.3	12.4	1.1	5.5	5.7	7.4	12.3	0.9	19.1	13.1	7.9	11.0	4.0	2.1	10.3	16.1	7.9	14.2	15.8	1.1	5.0	4.6	15.0	7.9	6.2	23.6	22.1	49.0	24.8	7.8	15.7	5.3	9.0	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	2.5	0.1	0.1	0.1	0.0	0.1	2.8	2.9	1.8	5.0	0.9	3.2	12.0	5.4	5.4	3.5	8.6	5.5	28.8	9.6	22.8	4.6	8.8	14.9	13.2	10.7	11.4	5.7	39.7	23.9	5.4	5.7	18.8	3.7	2.1	4.7	13.2	22.3	3.9	9.4	2.8	19.3	21.9	25.3	3.0	0.4	4.4	6.8	5.7	13.1	33.6	39.1	3.8	10.4	13.9	10.8	10.3	6.7	3.4	10.2	14.2	15.9	20.7	1.6	9.3	20.2	8.8	5.6	13.0	3.3	5.2	3.5	5.8	17.9	15.1	4.1	16.2	20.8	7.9	1.8	14.5	4.9	6.6	12.0	12.9	7.7	9.0	10.6	18.8	10.9	14.4	9.5	12.3	22.1
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690665-169711702	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 150.4;lymphoid tissue: 231.4"	"Group enriched"	"Detected in many"	5	"B-cells: 221.4;dendritic cells: 206.0;Kupffer cells: 68.9;Macrophages: 86.3;monocytes: 208.7;NK-cells: 110.2;T-cells: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 11.2;JURKAT: 29.4;MOLT-4: 21.2;U-266/70: 38.8;U-698: 19.4;U-937: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol		NA	NA		4700000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002144: AB_563862, HPA051972: AB_2797242"	"prognostic favorable (3.76e-4)"	"prognostic favorable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"	29.3	2.3	2.8	118.8	4.5	150.4	2.6	8.4	6.2	3.7	2.7	6.8	3.2	2.6	1.7	5.5	4.7	24.1	3.1	3.2	4.0	3.0	12.1	19.4	231.4	7.4	4.5	1.0	3.7	28.0	13.9	11.2	6.1	3.7	7.1	1.0	3.8	1.9	3.4	0.6	17.0	14.5	6.4	166.8	5.6	1.1	3.9	132.2	2.8	13.6	202.0	37.9	1.4	8.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.2	0.7	0.0	0.3	11.2	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	7.7	1.3	0.5	0.0	0.0	0.0	0.0	1.8	29.4	0.1	1.4	0.0	1.8	21.2	0.3	0.1	0.4	0.3	7.8	0.2	0.7	6.1	0.3	0.0	0.0	0.0	1.4	0.0	0.8	0.0	0.0	0.0	0.6	0.2	0.0	0.0	38.8	0.0	19.4	2.0	11.1	0.3	3688.4	992.6	1696.7	284.3	211.6	78.1	613.0	528.9	294.2	756.3	734.4	1169.2	683.6	4201.4	2551.1	93.1	622.9	1011.2	2052.5	2.8	4.5	8.4	6.2	3.2	4.0	7.4	4.5	6.1	6.4	3.9	8.0	1.8	9.6	13.7	0.7	221.4	0.4	0.3	0.0	0.6	0.1	0.5	0.3	0.6	2.8	1.8	11.0	0.0	13.9	206.0	0.1	0.0	0.2	0.0	0.1	0.0	3.4	0.0	25.2	0.2	0.0	0.6	3.3	2.6	0.1	10.1	0.5	3.9	1.1	5.6	0.0	0.1	0.1	0.0	68.9	2.7	0.2	0.6	86.3	1.8	1.0	208.7	2.5	110.2	0.0	0.8	0.1	0.0	0.0	25.8	0.0	0.0	0.9	1.5	0.0	0.0	0.2	0.6	0.0	0.1	0.3	0.1	28.5	104.9	0.5	0.0	0.6
SIGLEC5	"CD170, CD33L2, OB-BP2, SIGLEC-5"	ENSG00000105501	"Sialic acid binding Ig like lectin 5"	O15389	19	51611927-51645545	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 14.7;lymphoid tissue: 12.4"	"Cell type enhanced"	"Detected in some"		"granulocytes: 8.2;Hofbauer cells: 5.6;Kupffer cells: 10.4;Macrophages: 4.4;monocytes: 3.0"	"Cancer enriched"	"Detected in single"	5	"urothelial cancer: 1.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"neutrophil: 152.5;non-classical monocyte: 49.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 152.5;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"HMC-1: 59.2;U-937: 25.6"									"HPA009085, CAB024900"	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB024900: , HPA009085: AB_1079965"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	1.4	0.4	0.3	6.6	0.6	14.7	0.2	0.3	1.2	0.2	0.0	0.7	0.1	0.3	0.0	0.3	0.7	0.7	0.4	0.3	0.3	0.3	1.5	3.4	3.1	0.4	0.3	0.1	0.2	0.3	0.1	0.8	0.5	0.3	0.7	0.2	0.3	0.1	0.0	0.0	2.0	0.9	0.4	12.4	0.6	0.8	0.4	0.7	0.2	0.4	2.2	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	15.5	22.2	0.5	0.0	24.2	0.0	2.5	0.0	0.0	15.6	2.0	0.0	0.0	152.5	0.7	49.3	5.0	0.0	8.4	0.3	0.6	0.3	1.2	0.3	0.3	0.4	0.3	0.5	0.4	0.4	0.6	0.0	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	8.2	0.0	0.0	0.0	5.6	0.0	0.2	0.0	0.0	10.4	1.2	0.5	0.3	4.4	0.0	1.0	3.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1594.8"	"Group enriched"	"Detected in all"	6	"granulocytes: 1594.8;monocytes: 502.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome		NA	NA		44000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	5.4	1.6	1.3	28.6	1.3	52.2	1.9	1.2	4.2	1.2	0.1	2.1	1.5	0.8	0.8	1.3	2.2	11.2	1.6	1.4	0.8	1.2	3.1	19.4	11.0	0.7	0.8	0.7	1.3	0.3	0.6	2.8	1.3	0.8	1.8	1.2	1.7	0.9	0.8	0.8	2.8	3.2	0.9	24.5	1.5	0.6	2.1	4.5	0.9	1.5	4.3	8.1	0.8	1.9	0.2	0.0	0.2	0.1	0.3	0.5	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.8	0.4	7.1	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	14.9	54.0	0.1	0.2	0.3	0.0	8.0	0.5	1.1	0.0	0.2	0.4	0.1	0.0	76.2	0.2	0.0	3.3	0.2	0.0	0.1	10.8	0.3	0.1	0.2	0.2	0.0	0.5	0.0	0.0	58.9	1.6	0.7	0.1	0.4	0.3	0.1	0.1	0.1	1.1	13.4	0.2	6.1	502.2	868.9	7.3	419.7	10.3	2.8	6.5	5.7	175.2	3.4	8.8	5.5	1594.8	8.2	357.6	165.7	11.8	287.0	1.3	1.3	1.2	4.2	1.4	0.8	0.7	0.8	1.3	0.9	2.1	1.9	0.6	3.2	5.2	0.3	1.2	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.2	10.9	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.1	0.7	0.0	0.2	7.0	0.0	1.8	0.2	14.7	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	30.9	0.0	0.0	26.7	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088103-69104805	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 8096.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 5714.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 5714.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	404.6	114.9	48.8	799.8	50.5	8096.7	136.4	55.5	99.6	93.2	70.1	101.8	77.9	63.5	25.9	91.0	96.8	316.4	111.9	48.2	67.8	98.3	239.4	347.3	437.2	82.4	59.3	30.7	68.4	131.6	62.1	355.6	67.8	58.9	118.9	15.5	40.1	57.4	37.5	18.9	111.4	219.4	65.5	362.8	95.0	18.3	64.7	228.9	72.7	117.1	314.6	508.3	46.1	71.0	5.3	43.0	0.2	0.4	768.1	749.7	1.2	94.9	63.9	235.1	283.5	0.1	18.2	9.1	117.4	4.1	134.4	1.1	0.0	20.6	799.9	535.7	0.4	87.1	29.8	0.3	312.7	4442.1	914.9	306.8	1.1	641.5	39.2	223.8	1227.8	13.3	82.5	419.9	1239.9	0.2	18.7	2549.7	0.7	0.1	84.6	2.4	2.3	446.7	0.6	6.0	0.3	0.8	2.3	0.6	16.0	0.0	2.2	4346.8	2609.1	187.9	12.9	3.8	20.1	486.4	508.4	57.3	112.2	3546.9	1.2	2349.8	1105.3	2730.6	474.9	774.6	313.4	73.5	228.5	362.8	583.0	39.0	125.5	268.4	5714.1	962.8	693.6	631.9	392.6	1590.5	48.8	50.5	55.5	99.6	48.2	67.8	82.4	59.3	67.8	65.5	64.7	71.0	1081.4	112.2	198.1	0.7	592.0	175.9	12.5	38.3	8.6	1.1	16.0	28.2	21.2	21.5	57.5	33.1	0.0	10.2	2922.2	2.9	0.0	4.2	4.1	4.6	15.0	566.8	1.8	277.8	0.2	9.8	10.2	87.9	70.3	6.6	2343.1	0.4	636.1	22.1	847.1	0.0	0.5	1.7	0.0	1789.9	6618.2	8.4	7.5	3639.1	556.7	80.6	3188.2	1.4	1292.5	0.0	0.2	1.3	1.2	18.0	1740.9	12.2	0.3	4.7	45.6	5.0	72.3	22.8	97.5	0.9	2.2	8.7	141.8	14.2	2235.9	1.2	5.5	18.1
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150517-144191939	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.1;bone marrow: 56.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 85.0;granulocytes: 90.3;Langerhans cells: 271.6;Macrophages: 158.0;monocytes: 85.5;Suprabasal keratinocytes: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	7	"basophil: 22.6;classical monocyte: 68.4;eosinophil: 43.5;intermediate monocyte: 81.1;myeloid DC: 25.4;neutrophil: 81.7;non-classical monocyte: 87.0"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.4;granulocytes: 81.7;monocytes: 87.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 17.2;Karpas-707: 10.1;RH-30: 6.9;TIME: 8.3;U-266/70: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					NA	NA		1100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"	25.1	4.4	0.6	5.8	0.6	56.5	14.5	0.6	1.1	1.9	0.7	2.8	1.0	1.4	0.3	5.1	2.6	2.1	7.3	0.7	0.8	3.6	3.1	21.3	5.5	1.0	0.7	0.9	1.1	0.6	2.1	2.4	0.9	1.3	0.9	0.2	2.1	0.3	2.5	8.2	3.3	1.9	0.8	14.1	2.0	1.1	0.9	1.8	7.5	0.9	3.5	4.0	3.2	1.1	0.4	0.1	0.1	3.9	0.2	0.3	0.6	0.4	0.3	0.4	0.7	0.1	0.4	0.1	0.4	0.6	0.7	0.6	0.0	0.1	0.2	17.2	0.6	3.0	0.6	0.1	1.0	0.9	0.5	0.0	0.0	0.2	0.1	0.2	4.3	0.8	0.1	10.1	0.5	0.2	0.4	0.9	0.0	0.0	0.3	0.1	6.9	0.6	0.0	1.9	0.2	0.1	1.2	0.1	1.7	0.3	0.1	3.8	8.3	0.2	1.0	0.4	0.3	11.6	4.6	0.1	0.2	2.1	0.4	22.6	68.4	43.5	6.0	81.1	3.8	1.4	2.7	5.1	25.4	2.4	1.0	3.0	81.7	3.2	87.0	2.7	8.3	43.9	0.6	0.6	0.6	1.1	0.7	0.8	1.0	0.7	0.9	0.8	0.9	1.1	41.9	54.5	10.7	0.0	16.6	85.0	11.3	6.3	3.4	0.0	11.1	4.6	4.5	4.3	6.6	1.8	0.0	0.9	38.1	0.1	0.0	6.4	0.4	3.7	0.7	23.7	3.5	6.1	0.1	2.6	5.7	11.2	0.5	5.0	90.3	0.2	8.2	1.4	30.1	0.0	0.1	0.4	2.0	73.7	271.6	1.2	0.6	158.0	44.4	2.8	85.5	0.0	21.6	0.0	0.1	6.1	3.3	0.0	63.1	14.4	0.0	0.1	10.7	0.1	0.0	46.6	9.7	3.0	3.8	11.2	154.6	28.0	36.6	3.2	0.6	33.3
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.6;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 63.6;Ionocytes: 22.4;Macrophages: 41.1;monocytes: 57.5;Respiratory ciliated cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 477.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 477.4"	"Cell line enriched"	"Detected in some"	7	"Daudi: 59.7"					"Low region specificity"	"Detected in some"									NA	NA		240000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	21.7	2.7	0.6	23.9	0.9	31.6	1.3	0.7	2.8	4.3	1.4	3.8	2.4	1.3	0.4	4.1	5.3	22.5	2.3	0.5	0.7	2.4	10.1	22.5	39.0	1.5	1.0	1.5	4.3	0.7	0.9	20.7	1.7	1.8	3.0	0.1	1.5	0.9	0.6	0.3	4.6	6.3	0.8	56.6	7.3	0.6	1.0	11.7	1.2	7.9	42.0	17.8	1.2	1.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.7	1.1	0.0	1.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	1.4	0.0	0.0	11.6	65.2	0.3	24.6	14.5	10.3	40.3	8.4	29.0	14.1	32.2	27.0	39.4	477.4	36.1	9.9	2.6	6.1	40.4	0.6	0.9	0.7	2.8	0.5	0.7	1.5	1.0	1.7	0.8	1.0	1.0	0.2	0.0	6.7	0.0	11.0	0.0	0.5	4.3	0.0	0.0	0.2	0.0	1.5	7.2	11.8	0.0	0.0	0.8	10.9	0.1	0.0	63.6	0.0	0.3	0.0	1.4	0.0	1.3	0.2	0.4	0.2	1.9	13.3	0.2	5.1	0.1	3.3	1.0	13.9	0.0	0.0	0.0	22.4	18.6	1.0	0.0	0.0	41.1	0.0	1.9	57.5	0.3	20.6	0.0	0.1	3.6	0.0	0.0	2.7	8.0	0.0	0.6	25.4	0.1	6.6	2.5	1.2	0.1	0.0	0.1	0.0	1.4	10.9	6.5	0.2	14.5